Thumbi Ndung'u

Thumbi Ndung'u is a Kenyan-born HIV/AIDS researcher. He heads the HIV Pathogenesis Programme at the University of KwaZulu-Natal, a province of South Africa. In 2012 Ndung'u was awarded the Howard Hughes Medical Institute's International Early Career Scientist award. Ndung'u is the first scientist to clone HIV subtype C. Ndung'u holds a Ph.D. from the Harvard School of Public Health. As a graduate student at Harvard, Ndung'u worked with Max Essex at Harvard's AIDS Initiative. Ndung'u is Professor and Victor Daitz Chair in HIV/TB Research at the University of KwaZulu-Natal[1] and is a Max Planck Investigator at the KwaZulu-Natal Research Institute for Tuberculosis and HIV.[2] [3][4][5][6][7]

References
  1. http://www.ukzn.ac.za/news/2013/03/25/ukzn-s-new-victor-daitz-chair-in-hiv-tb-research
  2. "Max Planck Society strengthens research in infectious diseases". www.mpg.de. Retrieved 2017-11-16.
  3. "HIV Researcher Probes Vulnerabilities in the Virus for Clues to a Vaccine". Scientific American. Retrieved 2017-11-16.
  4. Howard Hughes Medical Institute/Thumbi Ndung'u, Ph.D.
  5. Harvard School of Public Health, Aids Initiative; Thumbi Ndung'u Archived 2014-04-07 at the Wayback Machine
  6. African Leadership Academy/DR. THUMBI NDUNG'U Archived 2012-06-15 at the Wayback Machine
  7. "KZN scientist makes HIV/Aids breakthrough | IOL News". Retrieved 2017-11-16.

See also
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.